Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Capital Leases: 2018-2024

Historic Capital Leases for Neurogene (NGNE) over the last 4 years, with Dec 2024 value amounting to $26,000.

  • Neurogene's Capital Leases fell 82.05% to $7,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $7,000, marking a year-over-year decrease of 82.05%. This contributed to the annual value of $26,000 for FY2024, which is 60.00% down from last year.
  • According to the latest figures from FY2024, Neurogene's Capital Leases is $26,000, which was down 60.00% from $65,000 recorded in FY2023.
  • Neurogene's Capital Leases' 5-year high stood at $65,000 during FY2023, with a 5-year trough of $26,000 in FY2024.
  • Moreover, its 2-year median value for Capital Leases was $45,500 (2023), whereas its average is $45,500.
  • Data for Neurogene's Capital Leases shows a maximum YoY slumped of 60.00% (in 2024) over the last 5 years.
  • Neurogene's Capital Leases (Yearly) stood at $65,000 in 2023, then slumped by 60.00% to $26,000 in 2024.